| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.683 | 0.015 | 0.769 | Analgesic | 0.677 0.016 CID_3559 0.769 0.008 CID_38282 | CID_38282 | |
| 0.659 | 0.003 | 0.659 | Dopamine uptake inhibitor | 0.495 0.003 CID_3559 0.293 0.004 CID_38282 | ||
| 0.601 | 0.004 | 0.601 | NMDA receptor antagonist | 0.491 0.004 CID_3559 0.534 0.004 CID_38282 | ||
| 0.597 | 0.004 | 0.756 | Dopamine antagonist | 0.756 0.004 CID_3559 0.163 0.024 CID_38282 | CID_3559 | |
| 0.599 | 0.008 | 0.599 | HERG channel blocker | 0.499 0.015 CID_3559 0.592 0.009 CID_38282 | ||
| 0.594 | 0.008 | 0.594 | Potassium channel (Voltage-sensitive) blocker | 0.492 0.015 CID_3559 0.571 0.009 CID_38282 | ||
| 0.585 | 0.004 | 0.743 | Dopamine D2 antagonist | 0.743 0.004 CID_3559 0.146 0.023 CID_38282 | CID_3559 | |
| 0.58 | 0.015 | 0.58 | Spasmolytic | 0.418 0.037 CID_3559 0.304 0.069 CID_38282 | ||
| 0.561 | 0.003 | 0.675 | Dopamine D1 antagonist | 0.675 0.003 CID_3559 0.303 0.005 CID_38282 | CID_3559 | |
| 0.568 | 0.023 | 0.584 | Cholesterol antagonist | 0.46 0.039 CID_3559 0.584 0.021 CID_38282 | CID_38282 | |
| 0.551 | 0.028 | 0.587 | Antiobesity | 0.371 0.077 CID_3559 0.587 0.022 CID_38282 | CID_38282 | |
| 0.52 | 0.004 | 0.52 | Alpha 1b adrenoreceptor antagonist | 0.423 0.005 CID_3559 0.115 0.031 CID_38282 | ||
| 0.507 | 0.004 | 0.721 | Dopamine D4 antagonist | 0.721 0.003 CID_3559 0.129 0.02 CID_38282 | CID_3559 | |
| 0.502 | 0.006 | 0.591 | 5 Hydroxytryptamine 2 antagonist | 0.591 0.005 CID_3559 0.162 0.04 CID_38282 | CID_3559 | |
| 0.496 | 0.003 | 0.496 | Alpha 1 adrenoreceptor agonist | 0.25 0.005 CID_3559 0.098 0.017 CID_38282 | ||
| 0.492 | 0.005 | 0.492 | Alpha 1 adrenoreceptor antagonist | 0.369 0.008 CID_3559 0.104 0.042 CID_38282 | ||
| 0.49 | 0.004 | 0.49 | NMDA 2 receptor antagonist | 0.304 0.005 CID_3559 0.391 0.004 CID_38282 | ||
| 0.498 | 0.012 | 0.793 | Anticonvulsant | 0.793 0.004 CID_3559 0.576 0.008 CID_38282 | CID_3559 | |
| 0.491 | 0.006 | 0.491 | Alpha adrenoreceptor antagonist | 0.358 0.011 CID_3559 0.132 0.043 CID_38282 | ||
| 0.484 | 0.004 | 0.605 | CC chemokine receptor antagonist | 0.466 0.004 CID_3559 0.605 0.004 CID_38282 | CID_38282 | |
| 0.487 | 0.012 | 0.487 | Potassium channel blocker | 0.447 0.016 CID_3559 0.369 0.028 CID_38282 | ||
| 0.468 | 0.005 | 0.468 | Antipruritic | 0.383 0.007 CID_3559 0.346 0.009 CID_38282 | ||
| 0.468 | 0.005 | 0.468 | 5 Hydroxytryptamine 1A antagonist | 0.403 0.005 CID_3559 0.104 0.031 CID_38282 | ||
| 0.464 | 0.004 | 0.493 | Histamine H1 receptor antagonist | 0.493 0.004 CID_3559 0.122 0.032 CID_38282 | CID_3559 | |
| 0.461 | 0.005 | 0.461 | Alpha 1a adrenoreceptor antagonist | 0.364 0.007 CID_3559 0.097 0.037 CID_38282 | ||
| 0.45 | 0.005 | 0.528 | 5 Hydroxytryptamine 2A antagonist | 0.528 0.004 CID_3559 0.128 0.035 CID_38282 | CID_3559 | |
| 0.445 | 0.005 | 0.604 | Chemokine receptor antagonist | 0.446 0.005 CID_3559 0.604 0.004 CID_38282 | CID_38282 | |
| 0.443 | 0.004 | 0.443 | Alpha 1d adrenoreceptor antagonist | 0.308 0.005 CID_3559 0.076 0.032 CID_38282 | ||
| 0.436 | 0.004 | 0.49 | Nav1.1 sodium channel blocker | 0.489 0.004 CID_3559 0.49 0.004 CID_38282 | CID_38282 | |
| 0.461 | 0.04 | 0.461 | Toll-Like receptor 7 agonist | 0.234 0.163 CID_38282 | ||
| 0.455 | 0.042 | 0.455 | Toll-Like receptor agonist | 0.226 0.172 CID_38282 | ||
| 0.418 | 0.006 | 0.418 | 5 Hydroxytryptamine 1 antagonist | 0.368 0.007 CID_3559 0.093 0.039 CID_38282 | ||
| 0.405 | 0.002 | 0.454 | CC chemokine 1 receptor antagonist | 0.454 0.002 CID_3559 0.173 0.004 CID_38282 | CID_3559 | |
| 0.407 | 0.008 | 0.61 | 5 Hydroxytryptamine 2B antagonist | 0.61 0.004 CID_3559 0.176 0.032 CID_38282 | CID_3559 | |
| 0.394 | 0.012 | 0.464 | 5 Hydroxytryptamine antagonist | 0.464 0.009 CID_3559 0.151 0.049 CID_38282 | CID_3559 | |
| 0.376 | 0.005 | 0.418 | Nav1.3 sodium channel blocker | 0.418 0.004 CID_3559 0.214 0.02 CID_38282 | CID_3559 | |
| 0.373 | 0.005 | 0.373 | Sigma receptor antagonist | 0.345 0.005 CID_3559 0.059 0.028 CID_38282 | ||
| 0.369 | 0.009 | 0.453 | Nav1.2 sodium channel blocker | 0.453 0.005 CID_3559 0.258 0.02 CID_38282 | CID_3559 | |
| 0.359 | 0.01 | 0.359 | Antiadrenergic | 0.181 0.028 CID_3559 0.092 0.061 CID_38282 | ||
| 0.349 | 0.005 | 0.349 | 5 Hydroxytryptamine uptake inhibitor | 0.199 0.011 CID_3559 0.281 0.007 CID_38282 | ||
| 0.353 | 0.01 | 0.353 | Adrenaline antagonist | 0.173 0.029 CID_3559 0.087 0.063 CID_38282 | ||
| 0.349 | 0.009 | 0.349 | Acetylcholine M1 receptor antagonist | 0.191 0.047 CID_3559 0.189 0.047 CID_38282 | ||
| 0.339 | 0.003 | 0.339 | Sigma 2 receptor antagonist | 0.306 0.003 CID_3559 0.028 0.018 CID_38282 | ||
| 0.338 | 0.004 | 0.338 | Alpha adrenoreceptor agonist | 0.151 0.016 CID_3559 0.171 0.012 CID_38282 | ||
| 0.332 | 0.005 | 0.449 | Dopamine D3 antagonist | 0.449 0.004 CID_3559 0.114 0.021 CID_38282 | CID_3559 | |
| 0.326 | 0.003 | 0.331 | Sphingosine 1-phosphate receptor 2 antagonist | 0.331 0.003 CID_3559 0.245 0.004 CID_38282 | CID_3559 | |
| 0.314 | 0.008 | 0.549 | 5 Hydroxytryptamine 2C antagonist | 0.549 0.004 CID_3559 0.175 0.021 CID_38282 | CID_3559 | |
| 0.335 | 0.039 | 0.335 | Hypolipemic | 0.156 0.131 CID_3559 | ||
| 0.344 | 0.054 | 0.375 | Calcium channel activator | 0.247 0.151 CID_3559 0.375 0.035 CID_38282 | CID_38282 | |
| 0.291 | 0.004 | 0.291 | Dopamine D5 antagonist | 0.201 0.005 CID_3559 0.068 0.016 CID_38282 | ||
| 0.378 | 0.097 | 0.378 | Calcium channel L-type activator | 0.266 0.188 CID_38282 | ||
| 0.285 | 0.004 | 0.325 | NMDA 2B receptor antagonist | 0.252 0.005 CID_3559 0.325 0.004 CID_38282 | CID_38282 | |
| 0.281 | 0.007 | 0.383 | Nav1.6 sodium channel blocker | 0.383 0.004 CID_3559 0.202 0.019 CID_38282 | CID_3559 | |
| 0.287 | 0.031 | 0.338 | P-glycoprotein inhibitor | 0.338 0.023 CID_3559 0.194 0.068 CID_38282 | CID_3559 | |
| 0.257 | 0.004 | 0.257 | Acetylcholine M5 receptor antagonist | 0.088 0.021 CID_3559 0.071 0.03 CID_38282 | ||
| 0.254 | 0.01 | 0.254 | Alpha 2c adrenoreceptor antagonist | 0.223 0.014 CID_3559 0.161 0.028 CID_38282 | ||
| 0.299 | 0.056 | 0.299 | Cardiotonic | 0.18 0.139 CID_3559 | ||
| 0.243 | 0.016 | 0.243 | Acetylcholine muscarinic antagonist | 0.137 0.053 CID_3559 0.115 0.073 CID_38282 | ||
| 0.233 | 0.008 | 0.233 | 5 Hydroxytryptamine 1F antagonist | 0.177 0.013 CID_3559 0.144 0.018 CID_38282 | ||
| 0.226 | 0.004 | 0.226 | Lanosterol 14 alpha demethylase inhibitor | 0.141 0.015 CID_3559 0.159 0.009 CID_38282 | ||
| 0.24 | 0.022 | 0.24 | Anesthetic local | 0.16 0.044 CID_3559 0.097 0.086 CID_38282 | ||
| 0.222 | 0.004 | 0.23 | CC chemokine 3 receptor antagonist | 0.23 0.004 CID_3559 0.072 0.016 CID_38282 | CID_3559 | |
| 0.276 | 0.061 | 0.276 | Interleukin agonist | 0.245 0.083 CID_38282 | ||
| 0.219 | 0.005 | 0.38 | 5 Hydroxytryptamine 5A antagonist | 0.38 0.003 CID_3559 0.142 0.008 CID_38282 | CID_3559 | |
| 0.216 | 0.006 | 0.266 | Sphingosine 1-phosphate receptor 5 antagonist | 0.266 0.003 CID_3559 0.243 0.004 CID_38282 | CID_3559 | |
| 0.23 | 0.021 | 0.246 | Calcium channel blocker | 0.246 0.018 CID_3559 0.126 0.081 CID_38282 | CID_3559 | |
| 0.221 | 0.015 | 0.221 | Bronchodilator | |||
| 0.222 | 0.019 | 0.32 | Alpha 2b adrenoreceptor antagonist | 0.32 0.008 CID_3559 0.25 0.014 CID_38282 | CID_3559 | |
| 0.211 | 0.008 | 0.22 | Pregnane X receptor agonist | 0.167 0.029 CID_3559 0.22 0.007 CID_38282 | CID_38282 | |
| 0.213 | 0.011 | 0.389 | 5 Hydroxytryptamine 7 antagonist | 0.389 0.005 CID_3559 0.202 0.012 CID_38282 | CID_3559 | |
| 0.27 | 0.073 | 0.298 | Ca(v)3.3 blocker | 0.298 0.044 CID_3559 | CID_3559 | |
| 0.202 | 0.007 | 0.202 | Acetylcholine M3 receptor antagonist | 0.063 0.038 CID_3559 0.062 0.039 CID_38282 | ||
| 0.2 | 0.005 | 0.338 | 5 Hydroxytryptamine 5 antagonist | 0.338 0.004 CID_3559 0.136 0.009 CID_38282 | CID_3559 | |
| 0.247 | 0.053 | 0.247 | Peptidyltransferase inhibitor | 0.183 0.123 CID_38282 | ||
| 0.193 | 0.006 | 0.293 | Adrenaline uptake inhibitor | 0.135 0.011 CID_3559 0.293 0.004 CID_38282 | CID_38282 | |
| 0.202 | 0.02 | 0.226 | Antihistaminic | 0.226 0.017 CID_3559 0.081 0.076 CID_38282 | CID_3559 | |
| 0.279 | 0.101 | 0.364 | Apoptosis antagonist | 0.333 0.064 CID_3559 0.364 0.05 CID_38282 | CID_38282 | |
| 0.35 | 0.173 | 0.35 | Antiinflammatory | 0.273 0.242 CID_3559 0.324 0.193 CID_38282 | ||
| 0.176 | 0.005 | 0.222 | NMDA 2A receptor antagonist | 0.088 0.017 CID_3559 0.222 0.004 CID_38282 | CID_38282 | |
| 0.18 | 0.009 | 0.18 | Adrenaline agonist | 0.091 0.045 CID_38282 | ||
| 0.197 | 0.026 | 0.272 | Adenylate cyclase inhibitor | 0.254 0.019 CID_3559 0.272 0.017 CID_38282 | CID_38282 | |
| 0.317 | 0.148 | 0.317 | Cyclophilin D inhibitor | |||
| 0.289 | 0.122 | 0.289 | Immunosuppressant | |||
| 0.183 | 0.022 | 0.217 | Histamine antagonist | 0.217 0.017 CID_3559 | CID_3559 | |
| 0.236 | 0.078 | 0.236 | Antiamyloidogenic | 0.178 0.116 CID_3559 | ||
| 0.164 | 0.015 | 0.164 | Electron transport complex I inhibitor | |||
| 0.181 | 0.032 | 0.181 | Cholesterol synthesis inhibitor | 0.154 0.042 CID_3559 0.127 0.059 CID_38282 | ||
| 0.237 | 0.095 | 0.526 | 5 Hydroxytryptamine uptake stimulant | 0.348 0.026 CID_3559 0.526 0.004 CID_38282 | CID_38282 | |
| 0.147 | 0.006 | 0.147 | Sphingosine 1-phosphate receptor antagonist | 0.119 0.013 CID_3559 0.104 0.019 CID_38282 | ||
| 0.188 | 0.049 | 0.188 | Interleukin 6 antagonist | |||
| 0.148 | 0.009 | 0.295 | Dopamine D4 agonist | 0.295 0.005 CID_3559 0.073 0.022 CID_38282 | CID_3559 | |
| 0.148 | 0.012 | 0.148 | Interleukin 5 antagonist | |||
| 0.175 | 0.04 | 0.175 | Cholinergic antagonist | 0.11 0.083 CID_3559 0.111 0.082 CID_38282 | ||
| 0.175 | 0.041 | 0.175 | Neurotrophic factor | 0.175 0.04 CID_3559 0.162 0.05 CID_38282 | ||
| 0.173 | 0.039 | 0.173 | Acetylcholine antagonist | 0.107 0.083 CID_3559 0.109 0.081 CID_38282 | ||
| 0.167 | 0.037 | 0.167 | Interleukin 4 antagonist | |||
| 0.153 | 0.023 | 0.153 | Sphingomyelinase inhibitor | 0.086 0.078 CID_38282 | ||
| 0.168 | 0.04 | 0.261 | Glutamate receptor antagonist | 0.17 0.039 CID_3559 0.261 0.014 CID_38282 | CID_38282 | |
| 0.134 | 0.007 | 0.181 | Neurokinin 2 antagonist | 0.126 0.008 CID_3559 0.181 0.004 CID_38282 | CID_38282 | |
| 0.156 | 0.03 | 0.175 | Ca2+-transporting ATPase inhibitor | 0.154 0.034 CID_3559 0.175 0.009 CID_38282 | CID_38282 | |
| 0.164 | 0.039 | 0.167 | Farnesoid X receptor antagonist | 0.156 0.045 CID_3559 0.167 0.037 CID_38282 | CID_38282 | |
| 0.138 | 0.017 | 0.159 | Dopamine agonist | 0.159 0.014 CID_3559 0.083 0.035 CID_38282 | CID_3559 | |
| 0.125 | 0.006 | 0.348 | NMDA receptor subunit 3A antagonist | 0.07 0.014 CID_3559 0.348 0.003 CID_38282 | CID_38282 | |
| 0.121 | 0.005 | 0.214 | Substance P antagonist | 0.078 0.008 CID_3559 0.214 0.004 CID_38282 | CID_38282 | |
| 0.129 | 0.014 | 0.154 | Leukotriene synthesis inhibitor | 0.127 0.014 CID_3559 0.154 0.009 CID_38282 | CID_38282 | |
| 0.229 | 0.115 | 0.295 | Lipoxygenase inhibitor | 0.295 0.074 CID_3559 0.241 0.106 CID_38282 | CID_3559 | |
| 0.195 | 0.082 | 0.281 | Neurotrophic factor enhancer | 0.281 0.024 CID_3559 0.206 0.07 CID_38282 | CID_3559 | |
| 0.188 | 0.077 | 0.191 | Platelet adhesion inhibitor | 0.191 0.076 CID_38282 | CID_38282 | |
| 0.118 | 0.011 | 0.157 | Cannabinoid CB2 receptor antagonist | 0.157 0.007 CID_3559 0.109 0.013 CID_38282 | CID_3559 | |
| 0.116 | 0.011 | 0.246 | NMDA 2C receptor antagonist | 0.077 0.027 CID_3559 0.246 0.004 CID_38282 | CID_38282 | |
| 0.186 | 0.082 | 0.186 | Non-steroidal antiinflammatory agent | 0.153 0.111 CID_3559 | ||
| 0.107 | 0.003 | 0.138 | GABA uptake inhibitor | 0.138 0.002 CID_3559 0.132 0.003 CID_38282 | CID_3559 | |
| 0.137 | 0.036 | 0.137 | Nav1.5 sodium channel blocker | 0.132 0.041 CID_38282 | ||
| 0.106 | 0.005 | 0.209 | Nociceptin (N/OFQ) receptor antagonist | 0.1 0.006 CID_3559 0.209 0.004 CID_38282 | CID_38282 | |
| 0.117 | 0.017 | 0.164 | Calcium channel L-type blocker | 0.164 0.008 CID_3559 0.084 0.035 CID_38282 | CID_3559 | |
| 0.119 | 0.022 | 0.179 | Cannabinoid receptor antagonist | 0.167 0.012 CID_3559 0.179 0.01 CID_38282 | CID_38282 | |
| 0.103 | 0.006 | 0.106 | Sigma 1 receptor antagonist | 0.106 0.006 CID_3559 | CID_3559 | |
| 0.185 | 0.089 | 0.185 | Insulin sensitizer | 0.179 0.096 CID_38282 | ||
| 0.103 | 0.01 | 0.142 | Neurokinin antagonist | 0.065 0.022 CID_3559 0.142 0.005 CID_38282 | CID_38282 | |
| 0.097 | 0.005 | 0.097 | Prostaglandin agonist | |||
| 0.103 | 0.013 | 0.111 | CC chemokine 2 receptor antagonist | 0.085 0.017 CID_3559 0.111 0.011 CID_38282 | CID_38282 | |
| 0.181 | 0.092 | 0.34 | Psychostimulant | 0.168 0.102 CID_3559 0.34 0.033 CID_38282 | CID_38282 | |
| 0.108 | 0.023 | 0.108 | Acetylcholine M4 receptor antagonist | 0.093 0.034 CID_3559 0.099 0.029 CID_38282 | ||
| 0.121 | 0.036 | 0.133 | Alpha 2 adrenoreceptor antagonist | 0.104 0.045 CID_3559 0.133 0.032 CID_38282 | CID_38282 | |
| 0.109 | 0.027 | 0.22 | Analgesic, opioid | 0.11 0.027 CID_3559 0.22 0.008 CID_38282 | CID_38282 | |
| 0.216 | 0.134 | 0.222 | Hypoxia-inducible factor 1 alpha inhibitor | 0.181 0.177 CID_3559 0.222 0.127 CID_38282 | CID_38282 | |
| 0.106 | 0.024 | 0.115 | Estrogen receptor alpha antagonist | 0.115 0.02 CID_3559 0.083 0.044 CID_38282 | CID_3559 | |
| 0.086 | 0.004 | 0.086 | Prostaglandin E2 agonist | 0.021 0.019 CID_3559 | ||
| 0.091 | 0.01 | 0.091 | CC chemokine 5 receptor antagonist | 0.089 0.01 CID_3559 0.078 0.014 CID_38282 | ||
| 0.093 | 0.013 | 0.11 | Dopamine transporter inhibitor | 0.067 0.022 CID_3559 0.11 0.01 CID_38282 | CID_38282 | |
| 0.128 | 0.048 | 0.198 | Calcium channel (voltage-sensitive) blocker | 0.198 0.017 CID_3559 0.106 0.076 CID_38282 | CID_3559 | |
| 0.096 | 0.017 | 0.1 | Phospholipase D inhibitor | 0.097 0.016 CID_3559 0.1 0.014 CID_38282 | CID_38282 | |
| 0.095 | 0.023 | 0.095 | Acetylcholine M2 receptor antagonist | |||
| 0.103 | 0.032 | 0.18 | Opioid kappa receptor antagonist | 0.117 0.025 CID_3559 0.18 0.012 CID_38282 | CID_38282 | |
| 0.075 | 0.005 | 0.103 | Nerve growth factor antagonist | 0.086 0.004 CID_3559 0.103 0.003 CID_38282 | CID_38282 | |
| 0.085 | 0.015 | 0.12 | MDM2 inhibitor | 0.103 0.006 CID_3559 0.12 0.004 CID_38282 | CID_38282 | |
| 0.117 | 0.047 | 0.118 | Toll-Like receptor 4 antagonist | 0.113 0.051 CID_3559 0.118 0.045 CID_38282 | CID_38282 | |
| 0.088 | 0.019 | 0.15 | Calcium channel T-type blocker | 0.15 0.007 CID_3559 0.083 0.021 CID_38282 | CID_3559 | |
| 0.072 | 0.003 | 0.072 | Ceramide glucosyltransferase inhibitor | 0.069 0.003 CID_3559 0.04 0.017 CID_38282 | ||
| 0.137 | 0.068 | 0.156 | Sodium channel blocker | 0.156 0.055 CID_38282 | CID_38282 | |
| 0.171 | 0.103 | 0.171 | Interleukin antagonist | |||
| 0.095 | 0.027 | 0.185 | Amidase inhibitor | 0.185 0.007 CID_3559 0.073 0.044 CID_38282 | CID_3559 | |
| 0.118 | 0.051 | 0.147 | 5-Lipoxygenase inhibitor | 0.147 0.039 CID_3559 0.142 0.041 CID_38282 | CID_3559 | |
| 0.076 | 0.01 | 0.102 | Neurokinin 1 antagonist | 0.043 0.025 CID_3559 0.102 0.006 CID_38282 | CID_38282 | |
| 0.107 | 0.043 | 0.186 | Opioid antagonist | 0.119 0.037 CID_3559 0.186 0.017 CID_38282 | CID_38282 | |
| 0.068 | 0.004 | 0.068 | Prostaglandin EP2 agonist | 0.027 0.013 CID_3559 | ||
| 0.133 | 0.07 | 0.173 | Sodium channel (voltage-gated) blocker | 0.173 0.041 CID_38282 | CID_38282 | |
| 0.217 | 0.157 | 0.313 | Antithrombotic | 0.313 0.08 CID_38282 | CID_38282 | |
| 0.193 | 0.133 | 0.258 | Neuropeptide Y2 antagonist | 0.233 0.073 CID_3559 0.258 0.049 CID_38282 | CID_38282 | |
| 0.218 | 0.16 | 0.218 | Interleukin 2 agonist | 0.197 0.194 CID_38282 | ||
| 0.08 | 0.023 | 0.093 | Beta 3 adrenoreceptor antagonist | 0.093 0.017 CID_38282 | CID_38282 | |
| 0.102 | 0.045 | 0.126 | Androgen antagonist | 0.077 0.07 CID_3559 0.126 0.03 CID_38282 | CID_38282 | |
| 0.094 | 0.039 | 0.181 | Alpha 2a adrenoreceptor antagonist | 0.139 0.025 CID_3559 0.181 0.017 CID_38282 | CID_38282 | |
| 0.107 | 0.052 | 0.143 | Creatine kinase inhibitor | 0.123 0.039 CID_3559 0.143 0.027 CID_38282 | CID_38282 | |
| 0.081 | 0.026 | 0.136 | Cannabinoid CB1 receptor antagonist | 0.107 0.014 CID_3559 0.136 0.009 CID_38282 | CID_38282 | |
| 0.059 | 0.005 | 0.059 | Prostaglandin D2 agonist | |||
| 0.214 | 0.16 | 0.239 | Vasodilator, peripheral | 0.239 0.136 CID_3559 0.225 0.149 CID_38282 | CID_3559 | |
| 0.172 | 0.12 | 0.338 | Cyclic AMP phosphodiesterase inhibitor | 0.223 0.078 CID_3559 0.338 0.029 CID_38282 | CID_38282 | |
| 0.067 | 0.017 | 0.085 | Potassium channel Kv1.3 blocker | 0.085 0.011 CID_3559 0.056 0.024 CID_38282 | CID_3559 | |
| 0.077 | 0.028 | 0.077 | Prostaglandin EP2 antagonist | |||
| 0.174 | 0.127 | 0.174 | Vasodilator | 0.155 0.149 CID_3559 | ||
| 0.155 | 0.109 | 0.206 | Anesthetic general | 0.151 0.113 CID_3559 0.206 0.071 CID_38282 | CID_38282 | |
| 0.054 | 0.009 | 0.054 | Heme oxygenase inhibitor | 0.049 0.015 CID_3559 | ||
| 0.109 | 0.066 | 0.194 | 5 Hydroxytryptamine 3A agonist | 0.171 0.025 CID_3559 0.194 0.017 CID_38282 | CID_38282 | |
| 0.067 | 0.023 | 0.067 | 5 Hydroxytryptamine 1A agonist | 0.063 0.024 CID_3559 | ||
| 0.068 | 0.024 | 0.068 | Beta 2 adrenoreceptor agonist | |||
| 0.064 | 0.021 | 0.064 | Leukotriene C antagonist | 0.057 0.037 CID_3559 0.053 0.051 CID_38282 | ||
| 0.08 | 0.04 | 0.152 | Opioid mu receptor antagonist | 0.092 0.035 CID_3559 0.152 0.017 CID_38282 | CID_38282 | |
| 0.063 | 0.024 | 0.065 | Pregnane X receptor antagonist | 0.053 0.051 CID_3559 0.065 0.021 CID_38282 | CID_38282 | |
| 0.135 | 0.098 | 0.164 | Sigma receptor agonist | 0.164 0.076 CID_3559 | CID_3559 | |
| 0.057 | 0.02 | 0.283 | NMDA receptor subunit 3B antagonist | 0.041 0.033 CID_3559 0.283 0.004 CID_38282 | CID_38282 | |
| 0.077 | 0.041 | 0.092 | Potassium channel (Tandem pore domain) blocker | 0.092 0.015 CID_3559 0.077 0.041 CID_38282 | CID_3559 | |
| 0.132 | 0.097 | 0.205 | Adenylate cyclase stimulant | 0.205 0.011 CID_38282 | CID_38282 | |
| 0.176 | 0.145 | 0.642 | 5 Hydroxytryptamine release stimulant | 0.182 0.139 CID_3559 0.642 0.011 CID_38282 | CID_38282 | |
| 0.043 | 0.011 | 0.043 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.036 | 0.006 | 0.036 | Prostaglandin EP4 agonist | |||
| 0.099 | 0.072 | 0.099 | Mediator release inhibitor | |||
| 0.089 | 0.063 | 0.091 | Glutamate release inhibitor | 0.091 0.06 CID_38282 | CID_38282 | |
| 0.095 | 0.069 | 0.181 | Nitric-oxide synthase inhibitor | 0.089 0.081 CID_3559 0.181 0.013 CID_38282 | CID_38282 | |
| 0.042 | 0.02 | 0.042 | Leukotriene C4 antagonist | |||
| 0.062 | 0.041 | 0.081 | Cannabinoid CB1 receptor agonist | 0.081 0.028 CID_3559 0.066 0.038 CID_38282 | CID_3559 | |
| 0.032 | 0.012 | 0.032 | DNA polymerase III inhibitor | 0.032 0.012 CID_3559 0.03 0.015 CID_38282 | ||
| 0.047 | 0.03 | 0.079 | Adenylate cyclase 1 inhibitor | 0.061 0.017 CID_3559 0.079 0.008 CID_38282 | CID_38282 | |
| 0.104 | 0.088 | 0.113 | Estrogen antagonist | 0.113 0.069 CID_3559 | CID_3559 | |
| 0.054 | 0.04 | 0.057 | Phosphodiesterase II inhibitor | 0.057 0.036 CID_38282 | CID_38282 | |
| 0.028 | 0.015 | 0.039 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 CID_3559 0.039 0.005 CID_38282 | CID_38282 | |
| 0.043 | 0.032 | 0.043 | Dopamine D2 agonist | |||
| 0.127 | 0.118 | 0.143 | Interferon gamma antagonist | 0.143 0.088 CID_38282 | CID_38282 | |
| 0.021 | 0.013 | 0.033 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.011 CID_3559 0.033 0.004 CID_38282 | CID_38282 | |
| 0.047 | 0.039 | 0.05 | Phosphodiesterase 2A inhibitor | 0.05 0.034 CID_38282 | CID_38282 | |
| 0.022 | 0.014 | 0.071 | Nociceptin (N/OFQ) receptor agonist | 0.021 0.015 CID_3559 0.071 0.005 CID_38282 | CID_38282 | |
| 0.244 | 0.237 | 0.374 | 5 Hydroxytryptamine release inhibitor | 0.292 0.174 CID_3559 0.374 0.095 CID_38282 | CID_38282 | |
| 0.073 | 0.066 | 0.089 | Viral attachment inhibitor | 0.088 0.036 CID_3559 0.089 0.034 CID_38282 | CID_38282 | |
| 0.014 | 0.007 | 0.014 | DNA polymerase III polC-type inhibitor | 0.014 0.007 CID_3559 0.014 0.008 CID_38282 | ||
| 0.188 | 0.181 | 0.248 | Transcription factor NF kappa B inhibitor | 0.248 0.129 CID_38282 | CID_38282 | |
| 0.038 | 0.033 | 0.064 | Thymidine kinase inhibitor | 0.064 0.012 CID_38282 | CID_38282 | |
| 0.166 | 0.163 | 0.221 | Nitric-oxide synthase stimulant | 0.221 0.059 CID_38282 | CID_38282 | |
| 0.041 | 0.038 | 0.046 | Mannosidase inhibitor | 0.046 0.03 CID_38282 | CID_38282 | |
| 0.113 | 0.11 | 0.161 | Cell wall synthesis inhibitor | 0.161 0.055 CID_38282 | CID_38282 | |
| 0.044 | 0.041 | 0.058 | Cholesterol esterase inhibitor | 0.058 0.02 CID_3559 0.049 0.032 CID_38282 | CID_3559 | |
| 0.069 | 0.068 | 0.103 | Vanilloid 4 agonist | 0.071 0.061 CID_3559 0.103 0.015 CID_38282 | CID_38282 | |
| 0.074 | 0.073 | 0.145 | Inducible nitric-oxide synthase inhibitor | 0.145 0.017 CID_38282 | CID_38282 | |
| 0.043 | 0.042 | 0.051 | 5 Hydroxytryptamine 1 agonist | 0.051 0.037 CID_3559 | CID_3559 | |
| 0.048 | 0.048 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.035 CID_38282 | CID_38282 | |
| 0.033 | 0.034 | 0.038 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.038 0.024 CID_3559 | CID_3559 | |
| 0.167 | 0.17 | 0.219 | 5 Hydroxytryptamine 1E antagonist | 0.219 0.109 CID_38282 | CID_38282 | |
| 0.074 | 0.078 | 0.137 | Histamine H2 receptor antagonist | 0.137 0.014 CID_3559 0.091 0.045 CID_38282 | CID_3559 | |
| 0.044 | 0.048 | 0.12 | Opioid agonist | 0.046 0.045 CID_3559 0.12 0.01 CID_38282 | CID_38282 | |
| 0.057 | 0.063 | 0.063 | Interferon inducer | 0.063 0.046 CID_38282 | CID_38282 | |
| 0.049 | 0.06 | 0.06 | Cannabinoid receptor agonist | 0.06 0.049 CID_3559 0.056 0.052 CID_38282 | CID_3559 | |
| 0.036 | 0.048 | 0.072 | Opioid mu receptor agonist | 0.072 0.019 CID_38282 | CID_38282 | |
| 0.045 | 0.059 | 0.12 | Opioid delta receptor antagonist | 0.12 0.026 CID_38282 | CID_38282 | |
| 0.048 | 0.064 | 0.068 | 5 Hydroxytryptamine 1D antagonist | 0.068 0.04 CID_3559 0.068 0.04 CID_38282 | CID_38282 | |
| 0.01 | 0.028 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.02 0.013 CID_38282 | CID_38282 | |
| 0.065 | 0.083 | 0.086 | Interferon agonist | 0.086 0.043 CID_3559 0.075 0.061 CID_38282 | CID_3559 | |
| 0.059 | 0.079 | 0.116 | Nicotinic alpha4beta2 receptor antagonist | 0.091 0.039 CID_3559 0.116 0.02 CID_38282 | CID_38282 | |
| 0.073 | 0.098 | 0.084 | CC chemokine 5 receptor agonist | 0.084 0.05 CID_3559 0.083 0.054 CID_38282 | CID_3559 | |
| 0.064 | 0.089 | 0.156 | Glycine receptor antagonist | 0.073 0.07 CID_3559 0.156 0.006 CID_38282 | CID_38282 | |
| 0.091 | 0.118 | 0.157 | Cyclooxygenase 3 inhibitor | 0.157 0.043 CID_38282 | CID_38282 | |
| 0.029 | 0.055 | 0.045 | Glycine transporter 2 inhibitor | 0.045 0.034 CID_3559 | CID_3559 | |
| 0.046 | 0.073 | 0.098 | 5 Hydroxytryptamine agonist | 0.058 0.057 CID_3559 0.098 0.034 CID_38282 | CID_38282 | |
| 0.126 | 0.153 | 0.174 | ATPase inhibitor | 0.174 0.065 CID_38282 | CID_38282 | |
| 0.042 | 0.069 | 0.116 | Nicotinic alpha3beta2 receptor antagonist | 0.108 0.006 CID_3559 0.116 0.005 CID_38282 | CID_38282 | |
| 0.035 | 0.063 | 0.121 | Melanin-concentrating hormone receptor 1 antagonist | 0.121 0.009 CID_3559 0.061 0.029 CID_38282 | CID_3559 | |
| 0.021 | 0.052 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.028 CID_38282 | CID_38282 | |
| 0.055 | 0.086 | 0.064 | Calcium channel P-type blocker | 0.064 0.042 CID_38282 | CID_38282 | |
| 0.041 | 0.072 | 0.061 | Sphingosine kinase 2 inhibitor | 0.061 0.03 CID_38282 | CID_38282 | |
| 0.039 | 0.071 | 0.097 | 5 Hydroxytryptamine 6 antagonist | 0.097 0.016 CID_38282 | CID_38282 | |
| 0.042 | 0.077 | 0.141 | Alpha 2 adrenoreceptor agonist | 0.141 0.007 CID_38282 | CID_38282 | |
| 0.011 | 0.047 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.008 CID_38282 | CID_38282 | |
| 0.018 | 0.054 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.016 CID_38282 | CID_38282 | |
| 0.016 | 0.053 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 CID_38282 | CID_38282 | |
| 0.235 | 0.272 | 0.393 | Caspase 9 stimulant | 0.252 0.251 CID_3559 0.393 0.115 CID_38282 | CID_38282 | |
| 0.026 | 0.063 | 0.053 | Glycine transporter inhibitor | 0.053 0.029 CID_38282 | CID_38282 | |
| 0.026 | 0.063 | 0.047 | Opioid kappa receptor agonist | 0.047 0.026 CID_38282 | CID_38282 | |
| 0.025 | 0.064 | 0.061 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.05 0.029 CID_3559 0.061 0.023 CID_38282 | CID_38282 | |
| 0.072 | 0.113 | 0.125 | Ferrochelatase inhibitor | 0.125 0.05 CID_38282 | CID_38282 | |
| 0.064 | 0.11 | 0.191 | HIV-1 integrase (Overall Integration) inhibitor | 0.1 0.055 CID_3559 0.191 0.013 CID_38282 | CID_38282 | |
| 0.018 | 0.065 | 0.04 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.039 0.016 CID_3559 0.04 0.015 CID_38282 | CID_38282 | |
| 0.061 | 0.108 | 0.118 | GABA B receptor agonist | 0.118 0.008 CID_38282 | CID_38282 | |
| 0.044 | 0.092 | 0.065 | Beta adrenoreceptor antagonist | 0.065 0.046 CID_38282 | CID_38282 | |
| 0.011 | 0.061 | 0.041 | Kynurenine 3 monooxygenase inhibitor | 0.041 0.009 CID_3559 | CID_3559 | |
| 0.022 | 0.071 | 0.04 | Alpha 1d adrenoreceptor agonist | 0.04 0.025 CID_38282 | CID_38282 | |
| 0.07 | 0.122 | 0.104 | Anabolic | 0.104 0.058 CID_38282 | CID_38282 | |
| 0.024 | 0.076 | 0.05 | Delayed rectifier potassium channel blocker | 0.05 0.011 CID_3559 | CID_3559 | |
| 0.027 | 0.08 | 0.072 | Phenylethanolamine N methyltransferase inhibitor | 0.072 0.005 CID_38282 | CID_38282 | |
| 0.067 | 0.119 | 0.077 | Ca(v)3.1 blocker | 0.077 0.069 CID_3559 | CID_3559 | |
| 0.04 | 0.094 | 0.08 | 5 Hydroxytryptamine 7 agonist | 0.08 0.013 CID_3559 0.068 0.021 CID_38282 | CID_3559 | |
| 0.073 | 0.128 | 0.141 | AMP-activated protein kinase stimulant | 0.141 0.034 CID_38282 | CID_38282 | |
| 0.029 | 0.086 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.035 CID_38282 | CID_38282 | |
| 0.011 | 0.075 | 0.024 | Dopamine D1 agonist | 0.024 0.013 CID_38282 | CID_38282 | |
| 0.063 | 0.127 | 0.149 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.096 0.058 CID_3559 0.149 0.027 CID_38282 | CID_38282 | |
| 0.089 | 0.153 | 0.128 | Interleukin 1 antagonist | 0.128 0.078 CID_3559 0.112 0.101 CID_38282 | CID_3559 | |
| 0.017 | 0.085 | 0.03 | MAP3K8 inhibitor | 0.03 0.017 CID_38282 | CID_38282 | |
| 0.075 | 0.145 | 0.118 | DOPA decarboxylase inhibitor | 0.099 0.079 CID_3559 0.118 0.048 CID_38282 | CID_38282 | |
| 0.038 | 0.108 | 0.079 | Phenylalanine 4-hydroxylase inhibitor | 0.079 0.038 CID_38282 | CID_38282 | |
| 0.03 | 0.1 | 0.063 | 5 Hydroxytryptamine 4 antagonist | 0.063 0.021 CID_3559 | CID_3559 | |
| 0.024 | 0.103 | 0.046 | Nicotinic receptor alpha3 subunit antagonist | 0.043 0.032 CID_3559 0.046 0.028 CID_38282 | CID_38282 | |
| 0.036 | 0.118 | 0.054 | Glucosylceramidase inhibitor | 0.054 0.04 CID_38282 | CID_38282 | |
| 0.053 | 0.142 | 0.075 | Neuropeptide Y antagonist | 0.075 0.067 CID_38282 | CID_38282 | |
| 0.014 | 0.104 | 0.041 | Farnesoid X receptor agonist | 0.041 0.022 CID_38282 | CID_38282 | |
| 0.015 | 0.11 | 0.037 | Glutamate (mGluR group II) agonist | 0.037 0.022 CID_3559 | CID_3559 | |
| 0.011 | 0.107 | 0.033 | Glutamate (mGluR2) agonist | 0.033 0.022 CID_3559 | CID_3559 | |
| 0.011 | 0.112 | 0.039 | Histamine H3 receptor antagonist | 0.039 0.035 CID_3559 | CID_3559 | |
| 0.046 | 0.15 | 0.145 | Glycine receptor agonist | 0.145 0.007 CID_38282 | CID_38282 | |
| 0.042 | 0.148 | 0.074 | HIV-1 integrase inhibitor | 0.074 0.044 CID_3559 | CID_3559 | |
| 0.014 | 0.121 | 0.048 | Acetylcholine M1 receptor agonist | 0.048 0.027 CID_38282 | CID_38282 | |
| 0.1 | 0.208 | 0.448 | Aldehyde oxidase inhibitor | 0.448 0.04 CID_38282 | CID_38282 | |
| 0.063 | 0.171 | 0.115 | Cyclooxygenase 1 inhibitor | 0.115 0.085 CID_3559 | CID_3559 | |
| 0.149 | 0.258 | 0.362 | Tyrosine 3 hydroxylase inhibitor | 0.195 0.144 CID_3559 0.362 0.014 CID_38282 | CID_38282 | |
| 0.012 | 0.121 | 0.035 | Opioid delta receptor agonist | 0.035 0.024 CID_38282 | CID_38282 | |
| 0.028 | 0.139 | 0.082 | Androgen agonist | 0.082 0.023 CID_38282 | CID_38282 | |
| 0.008 | 0.12 | 0.035 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.035 0.013 CID_38282 | CID_38282 | |
| 0.021 | 0.135 | 0.04 | Sphingosine kinase 1 inhibitor | 0.04 0.03 CID_38282 | CID_38282 | |
| 0.045 | 0.158 | 0.077 | Glutamate (mGluR6) antagonist | 0.077 0.028 CID_38282 | CID_38282 | |
| 0.044 | 0.158 | 0.067 | Exportin-1 inhibitor | 0.067 0.049 CID_38282 | CID_38282 | |
| 0.042 | 0.157 | 0.102 | Histamine N-methyltransferase inhibitor | 0.095 0.051 CID_3559 0.102 0.044 CID_38282 | CID_38282 | |
| 0.032 | 0.147 | 0.064 | Sphingosine kinase inhibitor | 0.064 0.033 CID_38282 | CID_38282 | |
| 0.016 | 0.132 | 0.127 | Dopamine D5 agonist | 0.127 0.003 CID_38282 | CID_38282 | |
| 0.017 | 0.133 | 0.026 | Hedgehog signaling activator | 0.026 0.023 CID_38282 | CID_38282 | |
| 0.033 | 0.15 | 0.07 | Purinergic P2X1 antagonist | 0.07 0.032 CID_38282 | CID_38282 | |
| 0.092 | 0.212 | 0.146 | Melanin inhibitor | 0.146 0.087 CID_38282 | CID_38282 | |
| 0.057 | 0.183 | 0.123 | Amylase inhibitor | 0.123 0.079 CID_38282 | CID_38282 | |
| 0.029 | 0.156 | 0.107 | Glutamate receptor agonist | 0.107 0.033 CID_3559 | CID_3559 | |
| 0.024 | 0.153 | 0.088 | 5 Hydroxytryptamine 2A agonist | 0.088 0.021 CID_38282 | CID_38282 | |
| 0.073 | 0.206 | 0.148 | Protein kinase stimulant | 0.148 0.07 CID_38282 | CID_38282 | |
| 0.023 | 0.156 | 0.069 | Carbamoyl phosphate synthetase inhibitor | 0.069 0.035 CID_38282 | CID_38282 | |
| 0.024 | 0.159 | 0.057 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.057 0.033 CID_3559 | CID_3559 | |
| 0.021 | 0.157 | 0.077 | Acetylcholine M5 receptor agonist | 0.077 0.036 CID_3559 | CID_3559 | |
| 0.05 | 0.187 | 0.086 | Triose-phosphate isomerase inhibitor | 0.086 0.066 CID_38282 | CID_38282 | |
| 0.07 | 0.209 | 0.164 | Interleukin 8 antagonist | 0.164 0.026 CID_38282 | CID_38282 | |
| 0.013 | 0.153 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.016 CID_38282 | CID_38282 | |
| 0.02 | 0.16 | 0.067 | 5 Hydroxytryptamine 2B agonist | 0.067 0.007 CID_38282 | CID_38282 | |
| 0.027 | 0.168 | 0.055 | Topoisomerase II beta inhibitor | 0.055 0.026 CID_38282 | CID_38282 | |
| 0.004 | 0.152 | 0.033 | Arginase inhibitor | 0.033 0.029 CID_38282 | CID_38282 | |
| 0.014 | 0.164 | 0.058 | Acetylcholine muscarinic agonist | 0.058 0.035 CID_38282 | CID_38282 | |
| 0.017 | 0.168 | 0.037 | AMPA 4 receptor antagonist | 0.037 0.032 CID_38282 | CID_38282 | |
| 0.075 | 0.226 | 0.181 | Arachidonic acid antagonist | 0.181 0.052 CID_38282 | CID_38282 | |
| 0.035 | 0.187 | 0.084 | GABA aminotransferase inhibitor | 0.078 0.05 CID_3559 0.084 0.042 CID_38282 | CID_38282 | |
| 0.121 | 0.273 | 0.227 | DNA synthesis inhibitor | 0.227 0.087 CID_38282 | CID_38282 | |
| 0.021 | 0.174 | 0.045 | CC chemokine 4 receptor antagonist | 0.045 0.036 CID_38282 | CID_38282 | |
| 0.004 | 0.162 | 0.019 | Cyclin T1 inhibitor | 0.019 0.011 CID_38282 | CID_38282 | |
| 0.029 | 0.192 | 0.081 | 5 Hydroxytryptamine 3 agonist | 0.081 0.026 CID_38282 | CID_38282 | |
| 0.026 | 0.193 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.095 0.036 CID_38282 | CID_38282 | |
| 0.015 | 0.183 | 0.049 | Carbonic anhydrase XIV inhibitor | 0.049 0.034 CID_38282 | CID_38282 | |
| 0.021 | 0.194 | 0.047 | Kainate receptor agonist | 0.047 0.018 CID_38282 | CID_38282 | |
| 0.011 | 0.184 | 0.026 | Integrin alpha2beta1 antagonist | 0.026 0.019 CID_38282 | CID_38282 | |
| 0.032 | 0.209 | 0.07 | CDC25A inhibitor | 0.07 0.056 CID_3559 | CID_3559 | |
| 0.043 | 0.22 | 0.149 | Cystathionine beta-synthase inhibitor | 0.106 0.07 CID_3559 0.149 0.041 CID_38282 | CID_38282 | |
| 0.01 | 0.191 | 0.039 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.039 0.018 CID_3559 | CID_3559 | |
| 0.054 | 0.235 | 0.098 | Microtubule formation inhibitor | 0.098 0.094 CID_38282 | CID_38282 | |
| 0.007 | 0.193 | 0.04 | Kainate receptor 2 antagonist | 0.04 0.022 CID_38282 | CID_38282 | |
| 0.02 | 0.208 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.032 CID_38282 | CID_38282 | |
| 0.088 | 0.278 | 0.214 | Succinate dehydrogenase inhibitor | 0.157 0.1 CID_3559 0.214 0.039 CID_38282 | CID_38282 | |
| 0.011 | 0.206 | 0.07 | 5 Hydroxytryptamine 2 agonist | 0.07 0.019 CID_38282 | CID_38282 | |
| 0.043 | 0.244 | 0.361 | GABA C receptor antagonist | 0.361 0.004 CID_38282 | CID_38282 | |
| 0.009 | 0.211 | 0.031 | 5 Hydroxytryptamine 6 agonist | 0.031 0.015 CID_38282 | CID_38282 | |
| 0.008 | 0.213 | 0.044 | Carbonic anhydrase VII inhibitor | 0.044 0.036 CID_38282 | CID_38282 | |
| 0.044 | 0.25 | 0.116 | NADH dehydrogenase inhibitor | 0.116 0.031 CID_38282 | CID_38282 | |
| 0.046 | 0.254 | 0.115 | Acetylcholinesterase inhibitor | 0.115 0.083 CID_3559 | CID_3559 | |
| 0.021 | 0.232 | 0.051 | Potassium channel (ATP-sensitive) activator | 0.051 0.028 CID_38282 | CID_38282 | |
| 0.014 | 0.228 | 0.052 | Integrin alpha2 antagonist | 0.052 0.01 CID_38282 | CID_38282 | |
| 0.022 | 0.236 | 0.053 | Potassium channel (Inward rectifier) activator | 0.053 0.029 CID_38282 | CID_38282 | |
| 0.037 | 0.254 | 0.085 | Antineoplastic alkaloid | 0.085 0.06 CID_38282 | CID_38282 | |
| 0.022 | 0.241 | 0.077 | Acetylcholine nicotinic antagonist | 0.077 0.058 CID_38282 | CID_38282 | |
| 0.041 | 0.262 | 0.102 | Beta glucuronidase inhibitor | 0.102 0.067 CID_38282 | CID_38282 | |
| 0.096 | 0.318 | 0.167 | Catenin beta inhibitor | 0.148 0.111 CID_3559 0.167 0.071 CID_38282 | CID_38282 | |
| 0.049 | 0.272 | 0.087 | D-Ala-D-Ala ligase inhibitor | 0.087 0.051 CID_38282 | CID_38282 | |
| 0.04 | 0.269 | 0.088 | Bile acid receptor antagonist | 0.088 0.078 CID_38282 | CID_38282 | |
| 0.019 | 0.254 | 0.093 | Purinergic P2X4 antagonist | 0.093 0.005 CID_38282 | CID_38282 | |
| 0.182 | 0.42 | 0.346 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.346 0.155 CID_38282 | CID_38282 | |
| 0.018 | 0.256 | 0.055 | GABA B receptor antagonist | 0.055 0.015 CID_38282 | CID_38282 | |
| 0.105 | 0.343 | 0.288 | RNA-directed DNA polymerase inhibitor | 0.288 0.034 CID_38282 | CID_38282 | |
| 0.022 | 0.262 | 0.06 | Alpha 1L adrenoreceptor agonist | 0.06 0.008 CID_38282 | CID_38282 | |
| 0.125 | 0.366 | 0.203 | 5 Hydroxytryptamine 3E antagonist | 0.203 0.058 CID_38282 | CID_38282 | |
| 0.033 | 0.277 | 0.108 | Prolactin inhibitor | 0.108 0.048 CID_38282 | CID_38282 | |
| 0.042 | 0.288 | 0.202 | Alpha-N-acetylglucosaminidase inhibitor | 0.202 0.033 CID_38282 | CID_38282 | |
| 0.013 | 0.261 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | 0.049 0.047 CID_38282 | CID_38282 | |
| 0.117 | 0.366 | 0.515 | GABA C receptor rho-3 antagonist | 0.515 0.022 CID_38282 | CID_38282 | |
| 0.03 | 0.282 | 0.063 | Ryanodine receptor antagonist | 0.063 0.029 CID_38282 | CID_38282 | |
| 0.07 | 0.329 | 0.195 | Tumour necrosis factor antagonist | 0.182 0.066 CID_3559 0.195 0.056 CID_38282 | CID_38282 | |
| 0.013 | 0.274 | 0.068 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.068 0.055 CID_38282 | CID_38282 | |
| 0.028 | 0.291 | 0.072 | Glutamate dehydrogenase inhibitor | 0.072 0.054 CID_38282 | CID_38282 | |
| 0.013 | 0.28 | 0.052 | GABA A receptor antagonist | 0.052 0.039 CID_38282 | CID_38282 | |
| 0.022 | 0.29 | 0.082 | Acetylcholine agonist | 0.082 0.063 CID_38282 | CID_38282 | |
| 0.012 | 0.281 | 0.056 | GABA receptor antagonist | 0.056 0.035 CID_38282 | CID_38282 | |
| 0.017 | 0.289 | 0.073 | CDC25B inhibitor | 0.073 0.035 CID_3559 | CID_3559 | |
| 0.033 | 0.305 | 0.096 | Protein kinase C gamma inhibitor | 0.096 0.084 CID_38282 | CID_38282 | |
| 0.012 | 0.288 | 0.041 | Histamine H1 receptor agonist | 0.041 0.036 CID_38282 | CID_38282 | |
| 0.045 | 0.323 | 0.117 | Cholinergic | 0.117 0.113 CID_3559 | CID_3559 | |
| 0.014 | 0.293 | 0.058 | Neuronal nicotinic receptor antagonist | 0.058 0.056 CID_38282 | CID_38282 | |
| 0.012 | 0.293 | 0.052 | 5 Hydroxytryptamine 3 antagonist | 0.052 0.045 CID_38282 | CID_38282 | |
| 0.031 | 0.313 | 0.394 | GABA C receptor agonist | 0.394 0.005 CID_38282 | CID_38282 | |
| 0.048 | 0.332 | 0.195 | Peroxidase inhibitor | 0.195 0.06 CID_38282 | CID_38282 | |
| 0.043 | 0.328 | 0.118 | Toll-Like receptor 2 antagonist | 0.118 0.08 CID_38282 | CID_38282 | |
| 0.012 | 0.299 | 0.051 | Nicotinic receptor alpha4 subunit antagonist | 0.051 0.03 CID_38282 | CID_38282 | |
| 0.072 | 0.363 | 0.167 | Phospholipase C inhibitor | 0.167 0.077 CID_38282 | CID_38282 | |
| 0.004 | 0.302 | 0.025 | Imidazoline I1 receptor antagonist | 0.025 0.01 CID_38282 | CID_38282 | |
| 0.021 | 0.326 | 0.054 | Dihydroorotate oxidase inhibitor | 0.054 0.04 CID_38282 | CID_38282 | |
| 0.035 | 0.341 | 0.104 | Bromodomain-containing protein 2 inhibitor | 0.104 0.036 CID_38282 | CID_38282 | |
| 0.005 | 0.32 | 0.107 | 5 Hydroxytryptamine 2C agonist | 0.107 0.007 CID_38282 | CID_38282 | |
| 0.014 | 0.338 | 0.074 | Histidine decarboxylase inhibitor | 0.074 0.047 CID_38282 | CID_38282 | |
| 0.011 | 0.337 | 0.058 | Pim-2 kinase inhibitor | 0.058 0.032 CID_38282 | CID_38282 | |
| 0.071 | 0.398 | 0.252 | Superoxide dismutase inhibitor | 0.195 0.123 CID_3559 0.252 0.073 CID_38282 | CID_38282 | |
| 0.017 | 0.348 | 0.087 | NMDA receptor agonist | 0.087 0.025 CID_38282 | CID_38282 | |
| 0.027 | 0.364 | 0.107 | UDP-glucose 4-epimerase inhibitor | 0.107 0.054 CID_38282 | CID_38282 | |
| 0.048 | 0.4 | 0.138 | Hexokinase inhibitor | 0.138 0.094 CID_38282 | CID_38282 | |
| 0.077 | 0.43 | 0.151 | Neurotensin receptor agonist | 0.151 0.098 CID_38282 | CID_38282 | |
| 0.073 | 0.431 | 0.218 | Gastrin inhibitor | 0.196 0.155 CID_3559 0.218 0.122 CID_38282 | CID_38282 | |
| 0.056 | 0.416 | 0.132 | MAP kinase 3 inhibitor | 0.132 0.103 CID_38282 | CID_38282 | |
| 0.016 | 0.378 | 0.105 | Pim-3 kinase inhibitor | 0.105 0.041 CID_38282 | CID_38282 | |
| 0.012 | 0.386 | 0.045 | Histamine H4 receptor antagonist | 0.045 0.041 CID_38282 | CID_38282 | |
| 0.055 | 0.433 | 0.161 | CF transmembrane conductance regulator agonist | 0.161 0.059 CID_38282 | CID_38282 | |
| 0.091 | 0.479 | 0.129 | Heat shock protein 70 antagonist | 0.129 0.128 CID_38282 | CID_38282 | |
| 0.039 | 0.429 | 0.123 | Neuropeptide Y1 antagonist | 0.123 0.116 CID_38282 | CID_38282 | |
| 0.029 | 0.42 | 0.126 | Electrolyte absorption antagonist | 0.126 0.032 CID_38282 | CID_38282 | |
| 0.068 | 0.461 | 0.163 | Death-associated protein kinase 2 inhibitor | 0.163 0.079 CID_38282 | CID_38282 | |
| 0.009 | 0.422 | 0.04 | Protein kinase (CK2) beta inhibitor | 0.04 0.012 CID_38282 | CID_38282 | |
| 0.024 | 0.44 | 0.207 | GABA C receptor rho-1 antagonist | 0.207 0.007 CID_38282 | CID_38282 | |
| 0.028 | 0.454 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.034 CID_38282 | CID_38282 | |
| 0.007 | 0.438 | 0.085 | NMDA receptor glycine site agonist | 0.085 0.025 CID_38282 | CID_38282 | |
| 0.013 | 0.451 | 0.068 | I kappa B kinase 2 inhibitor | 0.068 0.034 CID_38282 | CID_38282 | |
| 0.018 | 0.462 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | 0.059 0.049 CID_38282 | CID_38282 | |
| 0.04 | 0.485 | 0.22 | GABA C receptor rho-2 antagonist | 0.22 0.02 CID_38282 | CID_38282 | |
| 0.037 | 0.493 | 0.078 | 3C-Like protease (SARS coronavirus) inhibitor | 0.078 0.075 CID_38282 | CID_38282 | |
| 0.031 | 0.498 | 0.106 | Sphingosine 1-phosphate receptor 4 antagonist | 0.106 0.105 CID_38282 | CID_38282 | |
| 0.01 | 0.477 | 0.106 | Protein kinase C zeta inhibitor | 0.106 0.044 CID_38282 | CID_38282 | |
| 0.002 | 0.504 | 0.039 | Nicotinic alpha3beta4 receptor agonist | 0.039 0.011 CID_38282 | CID_38282 | |
| 0.002 | 0.527 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.013 CID_38282 | CID_38282 | |
| 0.012 | 0.548 | 0.079 | I kappa B kinase inhibitor | 0.079 0.063 CID_38282 | CID_38282 | |
| 0.102 | 0.645 | 0.215 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.215 0.126 CID_38282 | CID_38282 | |
| 0.032 | 0.6 | 0.152 | 3C-like protease (Human coronavirus) inhibitor | 0.152 0.098 CID_38282 | CID_38282 | |
| 0.002 | 0.587 | 0.029 | Nicotinic alpha4beta2 receptor agonist | 0.029 0.019 CID_38282 | CID_38282 | |
| 0.012 | 0.663 | 0.128 | Heat shock protein 90 alpha antagonist | 0.128 0.115 CID_38282 | CID_38282 | |
| 0.008 | 0.705 | 0.094 | MAP-kinase-activated kinase 2 inhibitor | 0.094 0.032 CID_38282 | CID_38282 | |
| 0.009 | 0.723 | 0.102 | MAP-kinase-activated kinase inhibitor | 0.102 0.038 CID_38282 | CID_38282 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |